Colorectal Cancer
📧 Sign up to get email alerts when something new happens for Colorectal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-09-09Clinical Trial Update: Chemokine-Modulatory Regimen for Recurrent Resectable Colorectal Cancer [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating a chemokine-modulatory regimen for recurrent resectable colorectal cancer was terminated with results …
-
CLINICAL_TRIALS trial_result · 2020-09-09Clinical Trial Update: Modufolin (Arfolitixorin) in Combination With 5-Fluorouracil Alone or Together With Oxaliplatin or Irinotecan in Colorectal Cancer [Phase 1, Phase 2]
Clinical trial updates on Modufolin (Arfolitixorin) with 5-fluorouracil, with/without oxaliplatin or irinotecan, in colorectal cancer (Phase…
-
FDA approval · 2020-09-04FDA Approved: OXALIPLATIN — Supplemental Application (Sagent Pharmaceuticals)
FDA approved a supplemental application for Oxaliplatin from Sagent Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2020-09-04Clinical Trial Update: Screen to Save: A Colorectal Cancer Educational Intervention [NA]
A completed clinical trial evaluating an educational intervention for colorectal cancer; results posted.
-
CLINICAL_TRIALS trial_result · 2020-09-03Clinical Trial Update: Chemoprevention of Colorectal Adenomas [Phase 3]
Phase 3 trial update for chemoprevention of colorectal adenomas has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-09-03Clinical Trial Update: Irinotecan Plus Brivanib in Metastatic Colorectal Cancer (CRC) Enriched for Elevated Levels of Plasma FGF [Phase 2]
Phase 2 trial of irinotecan plus brivanib in metastatic colorectal cancer with elevated plasma FGF was terminated; results posted but no pos…
-
CLINICAL_TRIALS trial_result · 2020-09-02Clinical Trial Update: Bevacizumab-containing Regimen for Metastatic Colorectal Cancer Failed to Cytotoxic Treatment [Phase 2]
Phase 2 trial assessing a bevacizumab-containing regimen for metastatic colorectal cancer did not achieve cytotoxic treatment goals.
-
CLINICAL_TRIALS trial_result · 2020-08-27Clinical Trial Update: Modelle 001, TS-inhibition in Colorectal Liver Metastases Comparing Arfolitixorin and Calciumfolinate [Phase 1, Phase 2]
A clinical trial update for Modelle 001 evaluating TS-inhibition in colorectal liver metastases comparing Arfolitixorin and Calciumfolinate …
-
CLINICAL_TRIALS trial_result · 2020-08-25Clinical Trial Update: Conversion Therapy of RAS/BRAF Wild-Type Right-sided Colon Cancer Patients With Initially Unresectable Liver Metastases [Phase 3]
Phase 3 trial evaluating conversion therapy for RAS/BRAF wild-type right-sided colon cancer with initially unresectable liver metastases.
-
CLINICAL_TRIALS trial_result · 2020-08-24Clinical Trial Update: MOBILE Trial. Mechanical and Oral Antibiotic Bowel Preparation Versus no Bowel preparatIon for eLEctive Colectomy - a Multicenter, Prospective, Randomized, Controlled Trial. [Phase 4]
A Phase 4 randomized trial evaluating mechanical and oral antibiotic bowel preparation versus no bowel preparation for elective colectomy in…
-
CLINICAL_TRIALS trial_result · 2020-08-21Clinical Trial Update: Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Previously-Treated Locally Advanced Unresectable or Metastatic Colorectal Cancer (MK-3475-164/KEYNOTE-164) [Phase 2]
Phase 2 trial of pembrolizumab as monotherapy in previously treated locally advanced unresectable or metastatic colorectal cancer completed …
-
CLINICAL_TRIALS trial_result · 2020-08-14Clinical Trial Update: ARQ 197 in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancer [Phase 1, Phase 2]
Clinical trial update for ARQ 197 in combination with chemotherapy in metastatic colorectal cancer; phases 1 and 2 completed with results po…
-
CLINICAL_TRIALS trial_result · 2020-08-12Clinical Trial Update: Cetuximab Re-challenge for Colorectal Cancer Liver Metastasis [Phase 3]
Phase 3 clinical trial investigating cetuximab re-challenge for colorectal cancer with liver metastases.
-
CLINICAL_TRIALS trial_result · 2020-08-06Clinical Trial Update: Enzastaurin for Patients With Metastatic Colorectal Cancer [Phase 2]
Phase 2 trial of enzastaurin for metastatic colorectal cancer has completed; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-08-06Clinical Trial Update: Circulating Tumour DNA Based Decision for Adjuvant Treatment in Colon Cancer Stage II Evaluation [Phase 3]
A Phase 3 clinical trial evaluating adjuvant treatment decisions in stage II colon cancer using circulating tumour DNA to guide therapy.
-
CLINICAL_TRIALS trial_result · 2020-08-05Clinical Trial Update: A Study of Radiotherapy Combined With Raltitrexed and Irinotecan in Metastatic or Locally Recurrent Colorectal Cancer [Phase 2]
Phase 2 clinical trial evaluating radiotherapy combined with raltitrexed and irinotecan in recurrent or metastatic colorectal cancer.
-
CLINICAL_TRIALS trial_result · 2020-08-03Clinical Trial Update: Amifostine Plus Irinotecan in Treating Patients With Metastatic Colorectal Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating amifostine plus irinotecan for metastatic colorectal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-07-27Clinical Trial Update: Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal Cancer [Phase 2]
Phase 2 clinical trial updating irinotecan use in metastatic or recurrent colorectal cancer.
-
CLINICAL_TRIALS trial_result · 2020-07-24Clinical Trial Update: A Study of Biomarker-Driven Therapy in Metastatic Colorectal Cancer (mCRC) [Phase 2]
Phase 2 biomarker-driven therapy trial in metastatic colorectal cancer sponsored by Hoffmann-La Roche has completed with results posted in J…
-
FDA approval · 2020-07-21FDA Approved: STIVARGA — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
FDA approved a supplemental application for Stivarga (regorafenib) from Bayer, expanding its approved uses.
-
CLINICAL_TRIALS trial_result · 2020-07-21Clinical Trial Update: A Study of Irinotecan Plus Cetuximab With or Without Enzastaurin in Participants With Colorectal Cancer [Phase 2]
Phase 2 trial evaluating irinotecan plus cetuximab with or without enzastaurin in colorectal cancer has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-07-21Clinical Trial Update: Study of Enzastaurin With 5-Fluorouracil/Leucovorin (5-FU/LV) Plus Bevacizumab as Maintenance Regimen Following First Line Therapy for Metastatic Colon Cancer [Phase 2]
Phase 2 trial evaluating enzastaurin with 5-FU/LV and bevacizumab as maintenance after first-line therapy in metastatic colorectal cancer ha…
-
CLINICAL_TRIALS trial_result · 2020-07-21Clinical Trial Update: A Study of AL2846 Capsule Combined With Standard Chemotherapy Regimen in Subjects With Advanced Colorectal Cancer [Phase 1, Phase 2]
Clinical trial update for AL2846 capsule combined with standard chemotherapy in advanced colorectal cancer across Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2020-07-20Clinical Trial Update: Efficacy of Preoperative Intravenous Iron in Anaemic Colorectal Cancer Surgical Patients [Phase 3]
Phase 3 trial evaluating preoperative intravenous iron for anaemic colorectal cancer surgical patients has completed.
-
CLINICAL_TRIALS trial_result · 2020-07-20Clinical Trial Update: A Study of DC-CIK Immunotherapy in the Treatment of Solid Tumors [Phase 2]
Phase 2 clinical trial update for DC-CIK immunotherapy in solid tumors; current status is unknown.